New blood test could replace risky needle tests for genetic diseases in pregnancy

NCT ID NCT03087526

Completed Diagnosis Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 24, 2026 · Updated 28 times

Summary

This study tested a new, safer way to check for certain genetic diseases during pregnancy using a simple blood draw from the mother. Researchers looked for fetal cells in the mother's blood to diagnose conditions like Huntington's disease and Fragile X syndrome. The goal was to see if this blood test gives the same results as the standard invasive tests (amniocentesis or chorionic villus sampling). 60 pregnant women at risk participated.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON INVASIVE PRENATAL DIAGNOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

CH Saint Brieuc

Saint-Brieuc, 22027, France
CHU Bordeaux

Bordeaux, 33076, France
CHU Montpellier

Montpellier, 34295, France
CHU Nice

Nice, 06202, France
CHU Nîmes

Nîmes, 30029, France
CHU Rennes

Rennes, 35203, France
CHU Strasbourg

Schiltigheim, 67303, France
CHU Toulouse

Toulouse, 31059, France

Conditions

Explore the condition pages connected to this study.

NON INVASIVE PRENATAL DIAGNOSIS NON INVASIVE PRENATAL DIAGNOSIS